Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 234,744 shares.
Evofem Biosciences Stock Performance
The firm’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01. The stock has a market capitalization of $1.13 million, a P/E ratio of -0.02 and a beta of -0.90.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Stories
- Five stocks we like better than Evofem Biosciences
- Ride Out The Recession With These Dividend KingsĀ
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 5 Top Rated Dividend Stocks to Consider
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.